China, Unhampered by Rules, Races Ahead in Gene-Editing Trials

U.S. scientists helped devise the Crispr biotechnology tool that has captured global attention for its potential to treat incurable diseases. The first to test it in humans are Chinese doctors, who don’t face the same regulatory hurdles as American counterparts.

Popular Posts


EOF

(Visited 4 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami